Tissue Instructive Materials Laboratory

Drexel University

An injectable material can become a platform for delivering treatment and influencing immune activity. Christopher Rodell studies biomaterials, supramolecular chemistry, and drug delivery, with applications in organ injury, cardiovascular engineering, immune engineering, and biomedical imaging. His research background includes injectable supramolecular hydrogels and platforms for innate immune activation in cancer immunotherapy. The lab connects molecular material design with therapeutic delivery problems. It is a useful research match for interests in minimally invasive biomaterials and the interaction between engineered materials and disease biology.